First Header Logo Second Header Logo

Connection

Lance Miller to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications Lance Miller has written about Cyclin-Dependent Kinase Inhibitor p16.
Lance Miller
Connection Strength
0.026
Cyclin-Dependent Kinase Inhibitor p16
  1. Maglic D, Zhu S, Fry EA, Taneja P, Kai F, Kendig RD, Sugiyama T, Miller LD, Willingham MC, Inoue K. Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer. Oncogene. 2013 Aug 29; 32(35):4120-9.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.